人福医药(600079) - 2014 Q1 - 季度财报
HWHGHWHG(SH:600079)2014-04-29 16:00

Financial Performance - Operating revenue for the first quarter rose by 16.58% to CNY 1,606,578,185.99 year-on-year [12]. - Net profit attributable to shareholders increased by 8.31% to CNY 92,671,901.89 compared to the same period last year [12]. - Basic and diluted earnings per share increased by 5.88% to CNY 0.18 per share [12]. - Total operating revenue for Q1 2014 was CNY 1,606,578,185.99, an increase of 16.6% compared to CNY 1,378,134,897.35 in Q1 2013 [14]. - Net profit attributable to shareholders of the parent company was CNY 92,671,901.89, a rise of 7.4% from CNY 85,561,421.45 in Q1 2013 [37]. - The company reported a total comprehensive income of CNY 136,464,388.03 for Q1 2014, compared to CNY 129,913,289.19 in Q1 2013 [37]. Cash Flow - Cash flow from operating activities was CNY 157,808,713.47, a significant recovery from a negative cash flow of CNY -90,998,105.56 in the previous year [12]. - Cash inflow from operating activities amounted to CNY 140,753,593.30, an increase of 50.8% compared to CNY 93,273,822.45 in the previous period [46]. - Cash outflow from investment activities totaled CNY 71,673,200.44, significantly reduced from CNY 289,270,350.47 in the previous period [46]. - Net cash flow from investment activities was -CNY 68,700,705.52, an improvement from -CNY 285,895,068.33 year-over-year [46]. - Financing activities generated a net cash inflow of CNY 124,768,032.32, down from CNY 483,808,498.35 in Q1 2013 [43]. - Net cash flow from financing activities decreased to CNY 46,422,943.14 from CNY 305,527,646.83, a decline of 84.8% [46]. Assets and Liabilities - Total assets increased by 3.81% to CNY 10,076,909,264.40 compared to the end of the previous year [11]. - The company's total assets amounted to CNY 1,007,690.93 million, an increase of CNY 36,990.43 million or 3.81% compared to the end of 2013 [19]. - Total liabilities increased, with accounts payable rising by 40.54% compared to the beginning of the period, attributed to the use of bank acceptance bills [19]. - Total liabilities rose to ¥4,912,162,048.41 from ¥4,626,658,965.19, which is an increase of about 6.2% [31]. - Total equity increased to ¥5,164,747,215.99 from ¥5,080,346,062.41, indicating a growth of about 1.7% [31]. Shareholder Information - The total number of shareholders reached 19,360 [15]. - The largest shareholder, Wuhan Contemporary Science and Technology Industry Group, holds 17.07% of the shares [15]. Government Subsidies and Non-Recurring Gains - The company received government subsidies amounting to CNY 4,948,274.90 during the quarter [13]. - The company reported a total of CNY 3,676,624.11 in net non-recurring gains and losses [13]. Investment and Management Expenses - The company's investment income decreased by 77.98% year-on-year, primarily due to the previous year's dividend income from financial institutions [19]. - The company's management expenses increased by 30.36% year-on-year, mainly due to rising costs of labor and daily expenses [19].